NCT07304154 2026-03-10A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic DiseasesGilead SciencesPhase 1 Not yet recruiting52 enrolled
NCT07392528 2026-02-11Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/ BCMA(QT-019C) in Patients With r/ r Neurological Autoimmune DiseasesTianjin Huanhu HospitalPhase EARLY_PHASE1 Not yet recruiting15 enrolled